Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancer.
about
Relative bioavailability of three formulations of galunisertib administered as monotherapy in patients with advanced or metastatic cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Relative bioavailability of th ...... advanced or metastatic cancer.
@en
Relative bioavailability of th ...... advanced or metastatic cancer.
@nl
type
label
Relative bioavailability of th ...... advanced or metastatic cancer.
@en
Relative bioavailability of th ...... advanced or metastatic cancer.
@nl
prefLabel
Relative bioavailability of th ...... advanced or metastatic cancer.
@en
Relative bioavailability of th ...... advanced or metastatic cancer.
@nl
P2093
P2860
P356
P1433
P1476
Relative bioavailability of th ...... advanced or metastatic cancer
@en
P2093
Analia Azaro
Ann Cleverly
Colin Miles
Durisala Desaiah
Elisabet Sicart
Irene Braña
Ivelina Gueorguieva
Jordi Rodon
Malcolm I Mitchell
Michael M Lahn
P2860
P304
P356
10.7573/DIC.212303
P50
P577
2016-12-02T00:00:00Z